BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


UK Shareholder Meetings Calendar - Next 7 Days


(Sharecast News) - BATM Advanced Communications revealed on Tuesday that chairman Gideon Chitayat had purchased 159,000 ordinary shares in the network...


DIRECTOR DEALINGS: BATM Advanced Communications Chair, CEO Buy Shares


BATM Expands Cyber Security Offering And Receives Follow-On Contract


BATM Excited For Future Prospects As Completes Delivery Under Arm Deal


(Sharecast News) - Real-time networking solutions and medical laboratory systems company BATM Advanced Communications confirmed details of its listing...


(Correcting that BATM will only become a constituent of several indices on the Tel-Aviv Stock Exchange).(Alliance News) - Real time technologies provi...


(Alliance News) - Real time technologies provider BATM Advanced Communications Ltd said Friday that it will be listed on the Tel-Aviv Stock Exchange i...